Rankings / Muscle & Strength

Other WADA-listed anabolic androgenic steroids (AAS long tail)

Muscle & Strength · Anabolic androgenic steroids / prohormones

Tier C+

High-risk evidence profile

Reviewed by Read Off Label · Last reviewed · How we grade

wadaanabolicandrogenbanned-sport
High-risk evidence profile
5.6 / 10
Tier C+
Ev 8 Bn 8 Sf 2

Bottom line

Read Off Label grades Other WADA-listed anabolic androgenic steroids (AAS long tail) as C+ (5.6/10) based on strong evidence, high benefit magnitude, and a high-risk safety profile.

Its high-risk evidence profile reflects a Safety score of 2/10; reported benefits and harms can differ by indication, dose, route, duration, and population.

WADA coverage: 1-Androstenediol, 1-Androstenedione, 1-Androsterone, 1-Epiandrosterone, 1-Testosterone, 4-Androstenediol, 4-Hydroxytestosterone, 5-Androstenedione, 7alpha-Hydroxy-DHEA, 7beta-Hydroxy-DHEA, 7-Keto-DHEA, 11beta-Methyl-19-nortestosterone, 17alpha-Methylepithiostanol (epistane), 19-Norandrostenediol, 19-Norandrostenedione, adrenosterone, androstanolone/DHT, androstenediol, androstenedione, bolasterone, boldione, calusterone, clostebol, danazol, dehydrochlormethyltestosterone/Turinabol, desoxymethyltestosterone, dimethandrolone, epiandrosterone, epi-dihydrotestosterone, epitestosterone, ethylestrenol, fluoxymesterone, formebolone, furazabol, gestrinone, mestanolone, methandriol, methasterone, methyl-1-testosterone, methylclostebol, methyldienolone, methylnortestosterone, methyltestosterone, metribolone/methyltrienolone, mibolerone, norboletone, norclostebol, norethandrolone, oxabolone, oxymesterone, prostanozol, quinbolone, stenbolone, tetrahydrogestrinone/THG, tibolone and trestolone/MENT.

Studied, labeled, or reported-use context: Highly variable; illicit use often cycle-based and medically unsupervised — Controlled/illegal without prescription in many countries; WADA S1 prohibited at all times; not individualized guidance.

What the evidence says

WADA coverage: 1-Androstenediol, 1-Androstenedione, 1-Androsterone, 1-Epiandrosterone, 1-Testosterone, 4-Androstenediol, 4-Hydroxytestosterone, 5-Androstenedione, 7alpha-Hydroxy-DHEA, 7beta-Hydroxy-DHEA, 7-Keto-DHEA, 11beta-Methyl-19-nortestosterone, 17alpha-Methylepithiostanol (epistane), 19-Norandrostenediol, 19-Norandrostenedione, adrenosterone, androstanolone/DHT, androstenediol, androstenedione, bolasterone, boldione, calusterone, clostebol, danazol, dehydrochlormethyltestosterone/Turinabol, desoxymethyltestosterone, dimethandrolone, epiandrosterone, epi-dihydrotestosterone, epitestosterone, ethylestrenol, fluoxymesterone, formebolone, furazabol, gestrinone, mestanolone, methandriol, methasterone, methyl-1-testosterone, methylclostebol, methyldienolone, methylnortestosterone, methyltestosterone, metribolone/methyltrienolone, mibolerone, norboletone, norclostebol, norethandrolone, oxabolone, oxymesterone, prostanozol, quinbolone, stenbolone, tetrahydrogestrinone/THG, tibolone and trestolone/MENT. This is a coverage row for the long tail; the common compounds keep individual pages. Additional WADA alias coverage: Androst-4-ene-3,11,17-trione (11-ketoandrostenedione, adrenosterone); Metandienone; Metenolone; Prostanozol (17beta-[(tetrahydropyran-2-yl)oxy]-1H-pyrazolo[3,4:2,3]-5alpha-androstane); RAD140 is covered by the dedicated RAD-140 row.

Mechanism

Synthetic and endogenous androgenic steroids bind the androgen receptor to increase nitrogen retention, lean mass and strength; this row covers WADA-listed long-tail AAS and precursors not already represented by the site's individual testosterone, nandrolone, trenbolone, oxandrolone, stanozolol and related pages.

Studied, labeled, or reported dose & route

Highly variable; illicit use often cycle-based and medically unsupervised

This records doses and routes described in studies, approved labeling, clinical practice, or documented use. It is not individualized guidance and does not establish safety; context changes with indication, formulation, health history, monitoring, and other medicines.

Citations

A link means the source informed this entry; it does not mean every claim on the page comes from that source. If a citation looks wrong or you want a claim re-checked, send a correction.

Common questions

What does the evidence show about Other WADA-listed anabolic androgenic steroids (AAS long tail)'s effects?
Read Off Label rates the evidence for Other WADA-listed anabolic androgenic steroids (AAS long tail) as Strong and the benefit magnitude as high, producing an overall grade of C+ (5.6/10). WADA coverage: 1-Androstenediol, 1-Androstenedione, 1-Androsterone, 1-Epiandrosterone, 1-Testosterone, 4-Androstenediol, 4-Hydroxytestosterone, 5-Androstenedione, 7alpha-Hydroxy-DHEA, 7beta-Hydroxy-DHEA, 7-Keto-DHEA, 11beta-Methyl-19-nortestosterone, 17alpha-Methylepithiostanol (epistane), 19-Norandrostenediol, 19-Norandrostenedione, adrenosterone, androstanolone/DHT, androstenediol, androstenedione, bolasterone, boldione, calusterone, clostebol, danazol, dehydrochlormethyltestosterone/Turinabol, desoxymethyltestosterone, dimethandrolone, epiandrosterone, epi-dihydrotestosterone, epitestosterone, ethylestrenol, fluoxymesterone, formebolone, furazabol, gestrinone, mestanolone, methandriol, methasterone, methyl-1-testosterone, methylclostebol, methyldienolone, methylnortestosterone, methyltestosterone, metribolone/methyltrienolone, mibolerone, norboletone, norclostebol, norethandrolone, oxabolone, oxymesterone, prostanozol, quinbolone, stenbolone, tetrahydrogestrinone/THG, tibolone and trestolone/MENT.
What safety findings are reported for Other WADA-listed anabolic androgenic steroids (AAS long tail)?
Other WADA-listed anabolic androgenic steroids (AAS long tail) has a high risk profile in the database. High (endocrine suppression, dyslipidemia, hypertension, hepatic strain for oral C17-aa agents, psychiatric effects, fertility suppression) Legal status: Controlled/illegal without prescription in many countries; WADA S1 prohibited at all times.
What does the low Safety score for Other WADA-listed anabolic androgenic steroids (AAS long tail) represent?
The Safety score is 2/10. It records the substantial harms described for one or more use contexts; the Benefit score, indication, dose, route, duration, population, and legal status remain separate parts of the evidence profile.
What doses or routes are reported for Other WADA-listed anabolic androgenic steroids (AAS long tail)?
Highly variable; illicit use often cycle-based and medically unsupervised This is context from studies, approved labeling, clinical practice, or documented use; it is not individualized guidance and does not establish safety.
How does Other WADA-listed anabolic androgenic steroids (AAS long tail) work?
Synthetic and endogenous androgenic steroids bind the androgen receptor to increase nitrogen retention, lean mass and strength; this row covers WADA-listed long-tail AAS and precursors not already represented by the site's individual testosterone, nandrolone, trenbolone, oxandrolone, stanozolol and related pages.

This is an independent synthesis of published research by a non-clinician. Scores are opinions supported by citations, not prescriptions. See the full disclaimer and methodology for how this score was produced and what it does and doesn't mean.